30 studies found for:    " August 27, 2008":" September 26, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism
Condition: HIV Infections
Interventions: Drug: Tenofovir + emtricitabine + efavirenz;   Drug: Tenofovir + emtricitabine + lopinavir/ritonavir
22 Completed
Has Results
Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment
Condition: HIV
Interventions: Drug: ritonavir;   Drug: darunavir;   Drug: emtricitabine [FTC]/tenofovir [TDF];   Drug: atazanavir
23 Active, not recruiting Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy
Conditions: HIV;   Hepatitis C;   Infections
Intervention: Drug: Pegylated interferon alfa and ribavirin (PEG-IFN/RBV)
24 Terminated
Has Results
A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071)
Condition: HIV
Interventions: Drug: Comparator: Raltegravir 400 mg b.i.d.;   Drug: Experimental: Raltegravir 800 mg q.d.;   Drug: TRUVADA™
25 Terminated A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects
Conditions: HIV;   Tuberculosis
Interventions: Drug: lopinavir/ritonavir;   Drug: rifabutin
26 Completed TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers.
Conditions: HIV;   AIDS
Intervention: Drug: Darunavir
27 Completed TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State.
Condition: HIV
Intervention: Drug: TMC278
28 Completed
Has Results
A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen
Conditions: Virus Diseases;   HIV
Intervention: Drug: Switch NRTIs as a Backbone to Raltegravir in HIV-Infected Patients from a Stable Boosted PI Regimen
29 Terminated
Has Results
Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)
Condition: Progressive Multifocal Leukoencephalopathy
Intervention: Drug: mefloquine
30 Completed Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
Conditions: Brain and Central Nervous System Tumors;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Other: educational intervention

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-30) Next Page   
Indicates status has not been verified in more than two years